LIR Life Sciences Corp.
SKNY
CNSX
| 07/31/2025 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Net Income | -102.00K | -33.20K | |||
| Total Depreciation and Amortization | 800.00 | -- | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 100.00 | -- | |||
| Change in Net Operating Assets | 66.00K | 17.10K | |||
| Cash from Operations | -35.10K | -16.00K | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -76.40K | -- | |||
| Cash from Investing | -76.40K | -- | |||
| Total Debt Issued | 35.00K | 62.50K | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | 25.50K | 45.60K | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | |||
| Net Change in Cash | -86.10K | 29.60K | |||